Berry Global Healthcare Division has a 50-year history of creating innovative solutions for healthcare partners to improve patient experiences, disease management, and environmental impact. They are a global leader in pharmaceutical packaging and medical devices with more than 15 healthcare-focused sites worldwide. Their solutions include child-resistant and senior-friendly packaging, ophthalmic and nasal platforms, respiratory drug delivery devices, and medical packaging. They use sustainability expertise and digital capabilities to create new products that improve quality of care while reducing costs. Their latest technology, the RS01X inhaler, connects to the Respiro app via Bluetooth to provide personalized reminders and inhaler technique tips. Visit Website
Harro Höfliger specializes in the development of customer-oriented process and production solutions for pharmaceutical and medical applications as well as market-oriented consumer products. In addition to innovative machine platforms and packaging machines, customized turnkey system solutions for product assembly, processing of web materials, as well as dosing and inhalation technology are the company’s core expertise.
The systematically structured portfolio of upscalable test machines and modules, as well as requirement-oriented technology platforms, results from many years of experience and targeted research and development. Thus, Harro Höfliger covers all phases from the laboratory stage to high-performance production. Visit Website
Our scientists provide development support for a wide range of pharmaceutical dosage forms with specialist expertise in OINDP development with integrated formulation and testing services for both small molecules and biologics. Our teams carry out early-stage pre-formulation support, solubility screening, drug-excipient compatibility, stability testing, and device selection support. For inhaled biologic development, comprehensive protein characterisation services supported by forced degradation and stability monitoring for the protein’s structure and bioactivity throughout formulation and storage can also be provided. Interaction with the device and closure systems are evaluated through comprehensive extractable and leachable testing and toxicological assessments.
With 30 years of experience in supporting our clients’ inhaled and nasal product developments, we deliver world-class support to help you meet the challenges of your demanding development programs. The Intertek Melbourn laboratory is inspected and approved by the UK Medicines & Healthcare Products Regulatory Agency (MHRA) for GMP compliance. The Laboratory has also been inspected by the US Food and Drug Administration (FDA) against GMP as part of clients’ pre-approval inspections. Visit Website
MUNIT is a company that specializes in the micronization of various types of pharmaceutical ingredients and compounds such as active pharmaceutical ingredients (APIs), high potent APIs, cytotoxic and cytostatic compounds, inhalation products, steroids, R&D compounds, and generics. The company is a combination of two affiliates, Jetpharma SA in Switzerland and Microchem Srl in Italy, with over 40 years of experience in the micronization sector.
MUNIT offers a range of services, including Jet, Pin, and Hammer milling, Cryogenic Micronization, Co-micronization, Sieving, Blending, De-Lumping, Technical trials, DoE Studies, Process development, and validation, QbD, and PSD analysis. MUNIT is your access point to Jetpharma’s and Microchem’s services, providing technical and commercial expertise in the micronization industry. Visit Website
Avient Corporation offers healthcare polymer solutions that help manufacturers of medical devices, diagnostic equipment, and pharmaceutical packaging mitigate risk and accelerate product development. Our Mevopur™ Healthcare Colorants and Formulations portfolio can be used to support brand recognition, drug identification, and increased appeal, while Mevopur™ Healthcare Functional Additives help enhance the properties or performance of plastics used in healthcare applications. They are provided as concentrates (a.k.a. masterbatches) for dilution into the polymer or as ready-to-use formulations. Visit Website
FLUIDDA is world leader in the field of QCT, and developer of Functional Respiratory Imaging. This technique combines HRCT scans and Computational Fluid Dynamics technology, which offers vast improvements by making clinical trials shorter, faster, and thus, more cost effective.
FRI also helps patients and healthcare providers in offering a unique entry point in personalized medicine, by optimizing diagnosis, monitoring disease progression and the effects of therapy, using their medical device called Broncholab®.
In this way, FLUIDDA is both a CRO services company and a partner of healthcare professionals by offering worldwide evidence for better respiratory treatment.
Our mission is to optimize treatment pathways, reduce healthcare costs and to limit the go-to-market time of respiratory drugs, pulmonology medical devices and therapies.
FLUIDDA was founded in 2005. Its head office is based in Kontich, Belgium, with subsidiaries in the USA and Portugal.
For more information and an up-to-date publication list, please visit www.fluidda.com
Nanopharm, an Aptar Pharma company is a leading provider of tailored analytical and drug development services, with a focus on orally inhaled and nasal drug products.
The company’s unique processing technologies and formulation development tools enable seamless translation of pre-clinical development through to clinical manufacturing. Nanopharm’s integrated development services in materials characterization, formulation development and inhaled biopharmaceutics aids successful product development by understanding how material properties and processing conditions influence product functionality.
Nanopharm span out of the University of Bath in 2002 with head facility in Cwmbran, Wales, United Kingdom. Since 2019, Nanopharm is part of Aptar Pharma services, world leading provider of devices for nasal and pulmonary delivery.
For more information and our entire list of scientific publications, please visit https://nanopharm.co.uk/
27-28 June, 2024 @Barcelona, Spain